Jou‐Ho Shih

415 total citations
10 papers, 292 citations indexed

About

Jou‐Ho Shih is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jou‐Ho Shih has authored 10 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Jou‐Ho Shih's work include RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and MRI in cancer diagnosis (1 paper). Jou‐Ho Shih is often cited by papers focused on RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and MRI in cancer diagnosis (1 paper). Jou‐Ho Shih collaborates with scholars based in Taiwan and United States. Jou‐Ho Shih's co-authors include Ruey‐Hwa Chen, Yuh‐Shan Jou, Yaw‐Dong Lang, En‐Chi Hsu, Ching‐Feng Cheng, Chian‐Feng Chen, Chiung-Tong Chen, Hsin‐Yi Chen, De-Leung Gu and Ruey‐Bing Yang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Cell Biology.

In The Last Decade

Jou‐Ho Shih

10 papers receiving 290 citations

Peers

Countries citing papers authored by Jou‐Ho Shih

Since Specialization

Citations

This map shows the geographic impact of Jou‐Ho Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jou‐Ho Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jou‐Ho Shih more than expected).

Fields of papers citing papers by Jou‐Ho Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jou‐Ho Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jou‐Ho Shih. The network helps show where Jou‐Ho Shih may publish in the future.

Co-authorship network of co-authors of Jou‐Ho Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Jou‐Ho Shih. A scholar is included among the top collaborators of Jou‐Ho Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jou‐Ho Shih. Jou‐Ho Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Paclitaxel-resistance facilitates glycolytic metabolism via Hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma 2024 ·Biomedicine & Pharmacotherapy ·Tsai‐Yu Lin, (unknown), Yi-Hui Lin, Jou‐Ho Shih, (unknown), Teh‐Ying Chou, Yu‐Ching Lee, Shwu‐Fen Chang, Yaw‐Dong Lang	3
2	Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer 2024 ·Theranostics ·Aushia Tanzih Al Haq, (unknown), Christopher Jin, Jou‐Ho Shih, Li‐Mei Chen, Hong‐Yu Tseng, Yen‐An Chen, Yueh‐Shan Weng, Lu‐Hai Wang, M Snyder, Hsin-Ling Hsu	16
3	Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression 2022 ·Journal of Hematology & Oncology ·Hsin-Yi Chen, (unknown), Xinxin Liu, An‐Chi Wei, (unknown), Kuan‐Wei Huang, Yaw‐Dong Lang, Jou‐Ho Shih, (unknown), (unknown), (unknown), (unknown), Pei‐Wen Hsiao, Yuh‐Shan Jou, Yunching Chen, Ruey‐Hwa Chen	19
4	Somatic A‐to‐I RNA‐edited RHOA isoform 2 specific‐R176G mutation promotes tumor progression in lung adenocarcinoma 2022 ·Molecular Carcinogenesis ·Kuan‐Ju Chen, (unknown), Jou‐Ho Shih, (unknown), (unknown), Roger Shen, (unknown), (unknown), (unknown), (unknown), (unknown), Hsin‐Yi Lee, Yaw‐Dong Lang, (unknown), Yuh‐Shan Jou	7
5	Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization 2021 ·European Radiology ·(unknown), Jou‐Ho Shih, (unknown), Nai‐Chi Chiu, Rheun‐Chuan Lee, (unknown), Chien‐An Liu	6
6	Usp11 controls cortical neurogenesis and neuronal migration through Sox11 stabilization 2021 ·Science Advances ·(unknown), (unknown), Shu‐Yu Lin, Hsin‐Yi Chen, (unknown), (unknown), Jou‐Ho Shih, Yi‐Shuian Huang, Hung‐Chih Kuo, Shen‐Ju Chou, Ruey‐Hwa Chen	27
7	PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression 2019 ·Nature Communications ·Yaw‐Dong Lang, Hsin‐Yi Chen, (unknown), Jou‐Ho Shih, En‐Chi Hsu, Roger Shen, Yu‐Ching Lee, (unknown), (unknown), (unknown), Ruey‐Hwa Chen, Yuh‐Shan Jou	31
8	Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma 2019 ·Nucleic Acids Research ·Jou‐Ho Shih, Hsin‐Yi Chen, (unknown), Yi‐Chen Yeh, Roger Shen, Yaw‐Dong Lang, (unknown), Chien‐Yu Chen, Ruey‐Hwa Chen, Teh‐Ying Chou, Yuh‐Shan Jou	28
9	Targeting protein tyrosine phosphatase PTP-PEST (PTPN12) for therapeutic intervention in acute myocardial infarction 2019 ·Cardiovascular Research ·Chiu-Fen Yang, Yiyun Chen, (unknown), (unknown), Yuwen Liu, (unknown), (unknown), (unknown), Jou‐Ho Shih, Shang‐Te Danny Hsu, Yuh‐Shan Jou, Ching‐Feng Cheng, Tzu‐Ching Meng	13
10	PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis 2018 ·Nature Cell Biology ·(unknown), En‐Chi Hsu, (unknown), Yaw‐Dong Lang, Yuh‐Charn Lin, (unknown), (unknown), De-Leung Gu, Jou‐Ho Shih, (unknown), Chian‐Feng Chen, Chiung-Tong Chen, (unknown), Ching‐Feng Cheng, Ruey‐Hwa Chen, Ruey‐Bing Yang, Yuh‐Shan Jou	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact